Idoia Rouco

781 total citations
12 papers, 574 citations indexed

About

Idoia Rouco is a scholar working on Neurology, Epidemiology and Surgery. According to data from OpenAlex, Idoia Rouco has authored 12 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 5 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Idoia Rouco's work include Parkinson's Disease Mechanisms and Treatments (5 papers), Neurological disorders and treatments (3 papers) and Restless Legs Syndrome Research (3 papers). Idoia Rouco is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (5 papers), Neurological disorders and treatments (3 papers) and Restless Legs Syndrome Research (3 papers). Idoia Rouco collaborates with scholars based in Spain. Idoia Rouco's co-authors include J.J. Zarranz, Juan Carlos Gómez‐Esteban, Beatriz Tijero, Elena Lezcano, Fernando Velasco, Roberto Ciordia, Joseba Bárcena, Koldo Berganzo, E. Lezcano and Johanne Somme and has published in prestigious journals such as SHILAP Revista de lepidopterología, Movement Disorders and JAMA Neurology.

In The Last Decade

Idoia Rouco

12 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Idoia Rouco Spain 8 477 179 119 105 68 12 574
Muhittin Cenk Akbostancı Türkiye 12 346 0.7× 66 0.4× 56 0.5× 87 0.8× 57 0.8× 56 479
Florian Brugger Switzerland 12 390 0.8× 47 0.3× 97 0.8× 144 1.4× 63 0.9× 39 599
Jorge Hernández‐Vara Spain 17 522 1.1× 96 0.5× 69 0.6× 153 1.5× 62 0.9× 42 679
Koldo Berganzo Spain 14 606 1.3× 89 0.5× 94 0.8× 103 1.0× 48 0.7× 20 718
Ayaka Numao Japan 10 257 0.5× 156 0.9× 89 0.7× 39 0.4× 42 0.6× 23 358
Mario Werkmann Austria 13 191 0.4× 48 0.3× 53 0.4× 55 0.5× 52 0.8× 25 521
Katharina A. Schindlbeck United States 14 346 0.7× 62 0.3× 153 1.3× 99 0.9× 52 0.8× 26 492
Jacopo Pasquini Italy 11 362 0.8× 75 0.4× 61 0.5× 130 1.2× 54 0.8× 23 530
Mariachiara Sensi Italy 15 492 1.0× 69 0.4× 68 0.6× 229 2.2× 49 0.7× 35 651
Annagrazia Cecere Italy 12 272 0.6× 93 0.5× 108 0.9× 99 0.9× 33 0.5× 26 454

Countries citing papers authored by Idoia Rouco

Since Specialization
Citations

This map shows the geographic impact of Idoia Rouco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Idoia Rouco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Idoia Rouco more than expected).

Fields of papers citing papers by Idoia Rouco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Idoia Rouco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Idoia Rouco. The network helps show where Idoia Rouco may publish in the future.

Co-authorship network of co-authors of Idoia Rouco

This figure shows the co-authorship network connecting the top 25 collaborators of Idoia Rouco. A scholar is included among the top collaborators of Idoia Rouco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Idoia Rouco. Idoia Rouco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Rouco, Idoia, et al.. (2016). Neurological manifestations in Erdheim-Chester disease: Two case reports. Neurología (English Edition). 31(6). 426–428. 1 indexed citations
3.
Rouco, Idoia, et al.. (2015). Hirayama disease: Is surgery an option?. SHILAP Revista de lepidopterología. 30(8). 502–509. 25 indexed citations
4.
Rouco, Idoia, P. Hurtado, Luís Castaño, & J.J. Zarranz. (2015). Experience with immunotherapy in 3 patients with cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies. Neurología (English Edition). 30(4). 247–249. 1 indexed citations
5.
Ariño, Helena, Núria Gresa‐Arribas, Yolanda Blanco, et al.. (2014). Cerebellar Ataxia and Glutamic Acid Decarboxylase Antibodies. JAMA Neurology. 71(8). 1009–1009. 122 indexed citations
6.
Rouco, Idoia, et al.. (2013). Enfermedad de Hirayama: ¿operar o no operar?. Neurología. 30(8). 502–509. 22 indexed citations
7.
Rouco, Idoia, et al.. (2013). Sporadic hyperekplexia presenting with an ataxic gait. Journal of Clinical Neuroscience. 21(2). 345–346. 1 indexed citations
8.
Gómez‐Esteban, Juan Carlos, Beatriz Tijero, Johanne Somme, et al.. (2010). Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson’s disease. Journal of Neurology. 258(3). 494–499. 117 indexed citations
9.
Gómez‐Esteban, Juan Carlos, J.J. Zarranz, Beatriz Tijero, et al.. (2007). Restless legs syndrome in Parkinson's disease. Movement Disorders. 22(13). 1912–1916. 94 indexed citations
10.
Gómez‐Esteban, Juan Carlos, J.J. Zarranz, E. Lezcano, et al.. (2007). Influence of Motor Symptoms upon the Quality of Life of Patients with Parkinson’s Disease. European Neurology. 57(3). 161–165. 99 indexed citations
11.
Gómez‐Esteban, Juan Carlos, J.J. Zarranz, Elena Lezcano, et al.. (2006). Sleep complaints and their relation with drug treatment in patients suffering from Parkinson's disease. Movement Disorders. 21(7). 983–988. 40 indexed citations
12.
Gómez‐Esteban, Juan Carlos, J.J. Zarranz, Fernando Velasco, et al.. (2005). Use of Ziprasidone in Parkinsonian Patients With Psychosis. Clinical Neuropharmacology. 28(3). 111–114. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026